Caspofungin Acetate Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-194

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Caspofungin Acetate (NDC 25021-194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mosteller Formula (Cas06 0000 01)

Mosteller Formula (Cas06 0000 01)
An illustration showing the formula to calculate Body Surface Area (BSA) in square meters, using height in centimeters and weight in kilograms divided by 3600 under a square root.*
FDA Label Image

Structural Formula (Cas06 0000 02)

Structural Formula (Cas06 0000 02)
Chemical structure of Caspofungin Acetate showing its detailed molecular arrangement including multiple rings, hydroxyl groups, amide bonds, and an acetate salt form with two acetic acid molecules.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cas06 0000 03)

Package Label – Principal Display Panel – Vial Label (Cas06 0000 03)
Label for Caspofungin Acetate Injection, 50 mg per vial, a single-dose vial for intravenous use. The lyophilized powder is manufactured by Sagent Pharmaceuticals. The label notes the vial contains the equivalent of 50 mg caspofungin acetate in 5.5 mg/mL concentration. It includes storage and dosage instructions and states the container closure is not made with natural rubber latex.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cas06 0000 04)

Package Label – Principal Display Panel – Vial Label (Cas06 0000 04)
Label for Caspofungin Acetate Injection, 70 mg per vial, lyophilized powder for intravenous use only, single-dose vial. The label indicates it is sterile and nonpyrogenic, with no natural rubber latex in the container, manufactured for Sagent Pharmaceuticals. The vial contains 70 mg caspofungin acetate equivalent to 77.7 mg caspofungin each, with instructions to reconstitute with 10.8 mL diluent to obtain a 7 mg/mL concentration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.